Siraya Consultancy

Fractional Chief Marketing Officer / Chief Business Officer, and Marketing Consultant

Serving MedTech, advanced manufacturing, and AI-enabled technology companies

Numbers Talk: Showcases with Measurable Results
These cases demonstrate how complex commercial challenges were unlocked through rapid diagnosis, clear structuring, and decisive orchestration across sales, marketing, business development, operation and management teams. In each case, the work began by identifying the real constraints holding teams back, then rebuilding the commercial logic into a coherent, effective and actionable framework.

Fractional CMO and CBO engagement supporting U.S. market entry and commercialization strategy for a medical technology company

Industry: MedTech
Product: FDA Class I & II Medical Devices

Objective

  • Establish a credible commercial foundation and reposition the company to pursue healthcare institutional contracts.

Challenge

  • Market penetration had stalled after prolonged efforts, due to stagnant distributor relationships, misaligned messaging, and unclear commercial priorities.

Solution

  • Reset the go-to-market approach, overhauled the sales architecture, implemented rigorous channel governance to ensure accountability, and developed a high-stakes commercial narrative specifically geared toward institutional buyers and stakeholders.

Outcomes

  • Secured an exclusive U.S. distribution partnership serving high-barrier Veterans Affairs (VA) and Department of Defense (DoD) healthcare systems, validating market readiness and unlocking a massive revenue channel.
Commercial strategy and go-to-market leadership for an advanced manufacturing company expanding into the U.S. market

Industry: Medical Device
Product: FDA Class II Surgical Tool


Objective

  • Translate FDA clearance into a high-velocity market strategy.

Challenge

  • A team with deep clinical expertise but lacking the commercial infrastructure required for scale. Key gaps included pricing logic, distribution legal frameworks, and fulfillment logistics.

Solution

  • Architected a structured GTM framework and defined optimal distributor profiles based on hospital purchasing dynamics.

Outcomes

  • Engaged a well-aligned U.S. distributor within 90 days of FDA clearance, and replaced commercial ambiguity with an executable market-entry path.
Commercial positioning and market expansion strategy for an industrial technology company in the sensing and LiDAR sector

Industry: Advanced Manufacturing
Product: LiDAR Systems for Automotive and Smart Mobility

Business Objective

  • Maximize market visibility and strengthen corporate positioning in advance of critical milestones, including a flagship product launch and heightened investor scrutiny.

Challenge

  • Severe time compression ahead of a high-impact industry event, compounded by a fragmented global brand image and insufficient marketing assets for international audiences.

Solution

  • Defined a launch framework aligned with corporate milestones and ideal customer profiles, integrating video, print, social, and event channels for maximum market reach.

Outcomes

  • Achieved 113% growth in audience engagement within two weeks, and established the commercial momentum and repeatable PR benchmarks.

*Subsequent milestone: The company completed an IPO in the months following this engagement.

Commercial positioning and market expansion strategy for an industrial technology company in the sensing and LiDAR sector

Industry: AI SaaS
Product: No-code AI & Machine Learning Platform

Objective

  • Increase U.S. market visibility and expand qualified lead generation to support Series A funding.

Challenge

  • Strong technology constrained by low brand recognition, product-centric messaging, and fragmented marketing efforts with limited performance tracking.

Solution

  • Reframed positioning around business outcomes and use cases, consolidating PR, digital, and event channels into a coordinated lead-generation funnel.

Outcomes

  • Recorded a 36.09% LinkedIn engagement rate, exceeded exhibition KPIs with 55% more leads and 30% more partner prospects, and reduced event costs by 10%.